Hennion & Walsh Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-52,339
| Closed | -$73K | – | 800 |
|
|
2023
Q1 | $73K | Sell |
52,339
-1,731
| -3% | -$2.41K | ﹤0.01% | 765 |
|
|
2022
Q4 | $108K | Sell |
54,070
-7,870
| -13% | -$15.7K | 0.01% | 755 |
|
|
2022
Q3 | $125K | Sell |
61,940
-3,184
| -5% | -$6.43K | 0.01% | 749 |
|
|
2022
Q2 | $207K | Sell |
65,124
-925
| -1% | -$2.94K | 0.01% | 719 |
|
|
2022
Q1 | $275K | Sell |
66,049
-4,464
| -6% | -$18.6K | 0.01% | 677 |
|
|
2021
Q4 | $338K | Buy |
70,513
+1,598
| +2% | +$7.66K | 0.02% | 622 |
|
|
2021
Q3 | $368K | Buy |
68,915
+20,745
| +43% | +$111K | 0.02% | 587 |
|
|
2021
Q2 | $247K | Buy |
+48,170
| New | +$247K | 0.01% | 668 |
|